Content
All Posts > Content under Press Releases/IR
Corvus Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Thursday, March 8, 2018 9:20 PM EDT
Corvus Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 7,058,824 shares of its common stock at a price to the public of $8.50 per share.
In this article: CRVS
Global Blood Therapeutics Announces Proposed Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Thursday, March 8, 2018 5:40 PM EDT
Global Blood Therapeutics, Inc. today announced a registered offering of 3,500,000 shares of its common stock.
In this article: GBT
Superconductor Technologies Announces Registered Direct Offering Priced At-The-Market
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, March 7, 2018 8:10 AM EDT
Superconductor Technologies Inc. announced that it has entered into a definitive purchase agreement with an institutional investor to purchase in a registered direct offering priced at-the-market 1,581,000 registered shares of its common stock.
In this article: SCON
Transunion Announces Pricing Of Secondary Offering Of 19,889,564 Shares Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, March 6, 2018 8:01 AM EDT
TransUnion announced the pricing of the underwritten secondary offering by certain of its stockholders of 19,889,564 shares of common stock of the Company.
In this article: TRU
Endocyte Announces Closing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Friday, March 2, 2018 9:35 PM EDT
Endocyte, Inc. announced today the closing of an underwritten registered public offering of 20,535,714 shares of its common stock.
In this article: ECYT
Hamilton Lane Announces Pricing Of Class A Common Stock Offering
Article By:
NASDAQ GlobeNewswire
Read
Thursday, March 1, 2018 12:06 PM EDT
Hamilton Lane Incorporated today announced the pricing of a public offering by Hamilton Lane and certain selling stockholders of 3,940,000 shares of Class A common stock.
In this article: HLNE
Endocyte Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, February 28, 2018 12:07 PM EDT
Endocyte, Inc. today the pricing of an underwritten registered public offering of 17,857,143 shares of its common stock at a price to the public of $4.20 per share.
In this article: ECYT
NMI Holdings, Inc. Announces Proposed Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Monday, February 26, 2018 4:43 PM EDT
NMI Holdings, Inc. today announced it has commenced an underwritten registered public offering of 3,700,000 shares of its Class A common stock, par value $0.01 per share.
In this article: NMIH
Herbalife Reports Fourth Quarter Reported Net Sales Growth Of 4.6% And Reiterates Growth Projections For 2018
Article By:
Business Wire
Read
Thursday, February 22, 2018 5:36 PM EDT
Herbalife Ltd. reports results for the fourth quarter and full year ended December 31, 2017.
In this article: HLF
OTEZLA (Apremilast) Phase III Data Showed Significant Improvements In Patients With Active Behçet’s Disease With Oral Ulcers
Article By:
Business Wire
Read
Saturday, February 17, 2018 4:15 PM EDT
Trial demonstrated statistically significant reductions in oral ulcers with apremilast 30mg versus placebo through week 12.
Significant improvements in key secondary endpoints, including oral ulcer pain, overall disease activity and quality of life.
In this article: CELG
WisdomTree Announces Changes To ETF Family
Article By:
NASDAQ GlobeNewswire
Read
Friday, February 16, 2018 4:09 PM EDT
WisdomTree (WETF), an exchange-traded fund and exchange-traded product sponsor and asset manager, today announced plans to close and liquidate nine of its ETFs. The Funds will no longer accept creation orders after Friday, March 16, 2018.
Catalyst Biosciences Announces Closing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Thursday, February 15, 2018 5:36 PM EDT
Catalyst Biosciences, today announced the closing of an underwritten public offering of 3,382,352 shares of its common stock, offered at a price of $34.00 per share to the public.
In this article: CBIO
Inpixon Prices $18M Public Offering
Article By:
NASDAQ GlobeNewswire
Read
Thursday, February 15, 2018 11:58 AM EDT
INPIXON today announced the pricing of a public offering with anticipated gross proceeds of approximately $18 million, before deducting placement agent fees and other offering expenses.
In this article: INPX
Catalyst Biosciences Announces The Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, February 13, 2018 12:50 PM EDT
Catalyst Biosciences, Inc. today announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock, offered at a price of $34.00 per share to the public.
In this article: CBIO
Litecoin Bullish Despite Potentially Scammy Fork Rumors
Article By:
Kiana Danial
Read
Tuesday, February 13, 2018 12:19 AM EDT
Is Litecoin Cash is moving towards the release of a new cryptocurrency that will be born from a hard fork of Litecoin?
In this article: LTC-X
Pacific Biosciences Of California, Inc. Announces Proposed Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Monday, February 12, 2018 5:44 PM EDT
Pacific Biosciences of California, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
In this article: PACB